Induction of nitric oxide synthase activity in pulmonary arteries from normoxic and chronically hypoxic rats

European Respiratory Journal

Volumn 10, Issue 2, 1997, Pages 437-445

  Carville, C ^a   Adnot, S ^a   Eddahibi, S ^a   Teiger, E ^a   Rideau, D ^a   Raffestin, B ^b  

^a HENRI MONDOR HOSPITAL   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

arginine analogues; endothelium derived relaxing factor; pulmonary circulation; pulmonary vascular reactivity

Indexed keywords

ARGININE DERIVATIVE; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; ENZYME ACTIVITY; HYPOXIA; LUNG ARTERY; LUNG CIRCULATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANOXIA; AORTA; CHRONIC DISEASE; DACTINOMYCIN; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; ENZYME INDUCTION; IMIDAZOLES; MALE; NITRIC OXIDE SYNTHASE; OMEGA-N-METHYLARGININE; PHENYLEPHRINE; POLYMERASE CHAIN REACTION; PULMONARY ARTERY; RATS; RATS, WISTAR; RNA, MESSENGER; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS;

EID: 0031048026     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.97.10020437     Document Type: Article

References (31)

1. Archer SL, Tolins JP, Raij L, Weir EK. Hypoxic pulmonary vasoconstriction is enhanced by inhibition of the synthesis of an endothelium derived relaxing factor. Biochem Biophys Res Commun 1989; 164: 1198-1205.
2. Liu S, Crawley DE, Barnes PJ, Evans TW. Endotheliumderived relaxing factor inhibits hypoxic pulmonary vasoconstriction in rats. Am Rev Respir Dis 1991; 143: 32-37.
3. Adnot S, Raffestin B, Eddahibi S, Braquet P, Chabrier PE. Loss of endothelium-dependent relaxant activity in the pulmonary circulation of rats exposed to chronic hypoxia. J Clin Invest 1991; 87: 155-162.
4. Kouyoumdjian C, Adnot S, Levame M, Eddahibi S, Bousbaa H, Raffestin B. Continuous inhalation of nitric oxide protects against development of pulmonary hypertension in chronically hypoxic rats. J Clin Invest 1994; 94: 578-584.
5. Kourembanas S, McQuillan LP, Leung GK, Faller DV. Nitric oxide regulates the expression of vasoconstrictors and growth factors by vascular endothelium under both normoxia and hypoxia. J Clin Invest 1993; 92: 99-104.
6. Tuder RM, Flook BE, Voelkel NF. Increased gene expression for VEGF and the VEGF receptors KDR/Flk and Flt in lungs exposed to acute and chronic hypoxia: modulation of gene expression by nitric oxide. J Clin Invest 1995; 95: 1798-1807.
7. Dinh-Xuan AT, Higenbottam TW, Colin A, et al. Impairment of endothelium-dependent pulmonary-artery relaxation in chronic obstructive lung disease. N Engl J Med 1991; 324: 1539-1547.
8. Carville C, Raffestin B, Eddahibi S, Blouquit Y, Adnot S. Loss of endothelium-dependent relaxation of large pulmonary arteries from rats exposed to chronic hypoxia: effects of in vitro and in vivo supplementation with L-arginine. J Cardiovasc Pharmacol 1993; 22: 889-896.
9. + channel-mediated relaxation. Am J Physiol 1992; 263 (Lung Cell Mol Physiol 7): L88-L94.
10. Resta TC, Walker BR. Chronic hypoxia selectively augments endothelium-dependent pulmonary arterial vasodilation. Am J Physiol 1996; 270 (Heart Circ Physiol 39): H888-H896.
11. Isaacson TC, Hampl V, Weir EK, Nelson DP, Archer SL. Increased endothelium-derived NO in hypertensive pulmonary circulation of chronically hypoxic rats. J Appl Physiol 1994; 76: 933-940.
12. Barer G, Emery CJ, Stewart A, Bee D, Howard P. Endothelial control of the pulmonary circulation in normal and chronically hypoxic rats. J Physiol (Lond) 1993; 463: 1-16.
13. Oka M, Hasunuma K, Webb S, Stelzner TJ, Rodman DM, McMurtry IF. EDRF suppresses an unidentified vasoconstrictor mechanism in hypertensive rat lungs. Am J Physiol 1993; 264 (Lung Cell Mol Physiol 8): L587-L597.
14. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991; 43: 109-142.
15. Le Cras TD, Xue C, Rengasamy A, Johns RA. Endothelial NO synthase mRNA and protein, and inducible NO synthase mRNA are upregulated in the rat lung following chronic hypoxia. Am J Physiol 1996; 270 (Lung Cell Mol Physiol 14): L164-L170.
16. Schini VB, Vanhoutte PM. Inhibitors of calmodulin impair the constitutive but not the inducible nitric oxide synthase activity in the rat aorta. J Pharmacol Exp Ther 1992; 261: 553-559.
17. Chomczynski P, Sacchi N. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-159.
18. Nunokawa Y, Ishida N, Tanaka S. Cloning of inducible nitric oxide synthase in rat vascular smooth muscle cells. Biochem Biophys Res Commun 1993; 191: 89-94.
19. Griffiths MJD, Liu S, Curzen NP, Messent M, Evans TW. In vivo treatment with endotoxin induces nitric oxide synthase in rat main pulmonary artery. Am J Physiol 1995; 268 (Lung Cell Mol Physiol 12): L509-518.
20. Schott CA, Gray GA, Stoclet JC. Dependence of endotoxin-induced vascular hyporeactivity on extracellular L-arginine. Br J Pharmacol 1993; 108: 38-43.
21. Xue C, Rengasamy A, Le Cras TD, Koberna PA, Dailey GC, Johns RA. Distribution of NOS in normoxic vs hypoxic rat lung: upregulation of NOS by chronic hypoxia. Am J Physiol 1994; 267 (Lung Cell Mol Physiol 11): L667-L678.
22. Kasahara Y, Tatsumi K, Nakano H, et al. The induction of inducible nitric oxide synthase in rat lungs with pulmonary hypertension. Am J Respir Crit Care Med 1995; 151: A728.
23. Eddahibi S, Adnot S, Carville C, Blouquit Y, Raffestin B. L-arginine restores endothelium-dependent relaxation in pulmonary circulation of chronically hypoxic rats. Am J Physiol 1992; 263 (Lung Cell Mol Physiol 7): L194-L200.
24. 2+-independent nitric oxide synthases. FEBS Lett 1991; 291: 145-149.
25. Robert R, Chapelain B, Jean T, Néliat G. Interleukin-1 impairs both vascular contraction and relaxation in rabbit isolated aorta. Biochem Biophys Res Commun 1992; 182: 733-738.
26. Shaul PW, North AJ, Brannon TS, et al. Prolonged in vivo hypoxia enhances nitric oxide synthase type I and type III gene expression in adult rat lung. Am J Respir Cell Mol Biol 1995; 13: 167-174.
27. 1 inhibits L-arginine-derived relaxing factor(s) from smooth muscle. Am J Physiol 1992; 262 (Heart Circ Physiol 31): H1788-H1795.
28. Kanno K, Hirata Y, Imai T, Marumo F. Induction of nitric oxide synthase gene by interleukin in vascular smooth muscle cells. Hypertension 1993; 22: 34-39.
29. α. J Clin Invest 1992; 90: 2333-2339.
30. Yan SF, Tritto I, Pinsky D, et al. Induction of interleukin-6 (IL-6) by hypoxia in vascular cells: central role of the binding site for nuclear factor-IL-6. J Biol Chem 1995; 270: 11463-11471.
31. Hampl V, Archer SL, Nelson DP, Weir EK. Chronic EDRF inhibition and hypoxia: effects on pulmonary circulation and systemic blood pressure. J Appl Physiol 1993; 75: 1748-1757.